Envista Holdings Corp (NVST)
Envista Schedules Fourth Quarter 2025 Earnings Call
9 Meters Biopharma, Inc. (NMTRQ)
DALL·E Version Comparison
ResMed Inc (RMD)
ResMed Inc. Q2 2026 Financial Results Conference Call
Savara Inc. (SVRA)
Savara Inc. - PANTHERx® Rare Selected by Savara as the U.S. Exclusive Specialty Pharmacy for MOLBREEVI*
ResMed Inc (RMD)
Resmed to Report Second Quarter Fiscal 2026 Earnings on January 29, 2026
ImmuCell Corporation (ICCC)
ImmuCell Announces Preliminary, Unaudited Sales Results for Q4 and Full Year of 2025
Eledon Pharmaceuticals Inc. (ELDN)
Eledon Pharmaceuticals Highlights Recent Business Milestones and Provides 2026 Outlook
Treace Medical Concepts Inc. (TMCI)
Treace Announces First Surgical Case Utilizing Lapiplasty® Lightning™ Technology
Veeva Systems Inc (VEEV)
Veeva to Present at the J.P. Morgan 2026 Healthcare Conference
Merit Medical Systems Inc (MMSI)
Merit Medical Appoints F. Ann Millner as Chair of the Board and Announces Projected Preliminary Unaudited Revenue Results for the Fourth Quarter of 2025